国金金融产品丨港股创新药ETF(513120):聚焦港股创新药,把握全球研发机遇

国金证券研究所
Aug 15

作者:于婧、王子薇摘要■投资逻辑广发中证香港创新药交易型开放式指数证券投资基金(代码513120.OF)采用指数化投资策略,紧密跟踪港股创新药指数,追求跟踪偏离度和跟踪误差的最小化,其风险收益特征与标的指数所表征的市场组合的风险收益特征相似。该基金于2022年7月1日成立,2022年7月12日上市。基金经理刘杰先生,超过20年证券、基金行业从业经历,目前管理在管产品19只,管理规模超840亿元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10